Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Molecular mechanisms driving maternal cardiac hypertrophy in pregnancy

EF 2022-23

Résumé
Cardiovascular disease is the leading cause of death globally; it is largely attributed to heart failure, when the heart loses its pumping ability. The opposite occurs in pregnancy, where the mother’s heart grows up to 50% in size and pumping force to deliver nutrients to the baby. This is termed cardiac remodeling and is a transient change that returns to baseline following delivery. Yet, there is limited knowledge on how pregnancy allows the mother's heart to be so dynamic. We aim to identify the signals and mechanisms that drive the change in the mother’s heart in pregnancy. Since the placenta helps communication between the baby and mother, we hypothesize that it releases signaling molecules (microRNAs) to alert the mother’s organs and help them prepare for pregnancy. We will use mice to characterize microscopic behavior of the mother’s heart on different pregnancy days. We will also give lab-grown human heart cells pregnancy signals in blood from pregnant mothers to see if the cells respond. Using a technique called gene sequencing, we will find genes that change in the heart cells in pregnancy, telling us which signals target the heart, and how the heart responds to start to grow. This allows better understanding of hypertensive disorders of pregnancy, which are linked with mothers’ poor cardiac remodeling and maternal and neonatal deaths. Molecular signals found here can also potentially be developed into therapeutics. Lastly, if these mechanisms allow increased cardiac strength in pregnancy, they should also be explored in cardiovascular research as methods of rescue for failing hearts. This study transforms women’s health by increasing gestational safety and provides new ideas to tackle the deadliest condition in the world in cardiovascular disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486024
Name
Lin Zi Qi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Molecular mechanisms driving maternal cardiac hypertrophy in pregnancy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cardiac Hypertrophy; Cardiac Remodeling; Cardiovascular Disease; Gestational Hypertension; Maternal Heart; Preeclampsia; Pregnancy; Pregnancy Complications; Sequencing
Abstract
Cardiovascular disease is the leading cause of death globally; it is largely attributed to heart failure, when the heart loses its pumping ability. The opposite occurs in pregnancy, where the mother’s heart grows up to 50% in size and pumping force to deliver nutrients to the baby. This is termed cardiac remodeling and is a transient change that returns to baseline following delivery. Yet, there is limited knowledge on how pregnancy allows the mother's heart to be so dynamic. We aim to identify the signals and mechanisms that drive the change in the mother’s heart in pregnancy. Since the placenta helps communication between the baby and mother, we hypothesize that it releases signaling molecules (microRNAs) to alert the mother’s organs and help them prepare for pregnancy. We will use mice to characterize microscopic behavior of the mother’s heart on different pregnancy days. We will also give lab-grown human heart cells pregnancy signals in blood from pregnant mothers to see if the cells respond. Using a technique called gene sequencing, we will find genes that change in the heart cells in pregnancy, telling us which signals target the heart, and how the heart responds to start to grow. This allows better understanding of hypertensive disorders of pregnancy, which are linked with mothers’ poor cardiac remodeling and maternal and neonatal deaths. Molecular signals found here can also potentially be developed into therapeutics. Lastly, if these mechanisms allow increased cardiac strength in pregnancy, they should also be explored in cardiovascular research as methods of rescue for failing hearts. This study transforms women’s health by increasing gestational safety and provides new ideas to tackle the deadliest condition in the world in cardiovascular disease.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lin, Zi Qi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~